KIJI Therapeutics Overview
- Year Founded
-
2023
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
KIJI Therapeutics General Information
Description
Operator of a biotech company intended to deliver an IPSC-MSC-engineered cell therapy for inflammatory disease. The company offers a platform to gene-engineer iPSC-derived MSC cells for a targeted and optimized therapeutic benefit, and the asset is engineered with IL10/CXCR4 and targets several autoimmune diseases, enabling patients to treat various inflammatory diseases.
Contact Information
Website
www.kiji-tx.com(Operating Subsidiary)
Corporate Office
- 4 rue Thenard
- 75005 Paris
- France
Corporate Office
- 4 rue Thenard
- 75005 Paris
- France
KIJI Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 27-Mar-2025 | Completed | Startup | |||
| 1. Early Stage VC | 17-Feb-2023 | Completed | Startup |
KIJI Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
KIJI Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
KIJI Therapeutics Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AdBio partners | Venture Capital | Minority |
KIJI Therapeutics FAQs
-
When was KIJI Therapeutics founded?
KIJI Therapeutics was founded in 2023.
-
Where is KIJI Therapeutics headquartered?
KIJI Therapeutics is headquartered in Paris, France.
-
What is the size of KIJI Therapeutics?
KIJI Therapeutics has 5 total employees.
-
What industry is KIJI Therapeutics in?
KIJI Therapeutics’s primary industry is Biotechnology.
-
Is KIJI Therapeutics a private or public company?
KIJI Therapeutics is a Private company.
-
What is KIJI Therapeutics’s current revenue?
The current revenue for KIJI Therapeutics is .
-
Who are KIJI Therapeutics’s investors?
AdBio partners has invested in KIJI Therapeutics.
-
When was KIJI Therapeutics acquired?
KIJI Therapeutics was acquired on 27-Mar-2025.
-
Who acquired KIJI Therapeutics?
KIJI Therapeutics was acquired by Regimmune.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
